Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Clinical relevance of the ACTL6A-GCLC-GSH metabolism axis in ferroptosis of GC cells Next, we sought to determine the clinical relevance of ACTL6A in regulating GCLC and inhibiting ferroptosis in a patient-derived xenograft (PDX) model
Lilly has submitted orforglipron for approval in more than 40 countries
Most commercially insured patients will pay $25-$300 per month through manufacturer copay cardsdramatically lower than list prices
Despite deep preclinical investigations of liver repair and regeneration mechanisms and the proven high potential of clinical trials, safety issues should not be underestimated
US$ 22.04
US$ 22.03
US$ 29.30
US$ 27.67
US$ 26.45
